Leukemia Clinical Trials in Texas

Showing 1241-1260 of 1,290 trials

A Phase 1-2, Multicenter, Open-Label Study of AEG35156 in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia and Indolent B-Cell Lymphomas

NCT00768339

AEG35156 has shown early evidence of activity in patients with advanced indolent B-cell lymphomas in Phase 1 trials and merits further evaluation in this disease. This trial is designed to determine the recommended dose of AEG35156 in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) and indolent B-cell lymphomas.

Leukemia, Lymphocytic, Chronic, B-CellLymphoma, B-Cell

Aegera Therapeutics25 participantsStarted Sep 2008

Burbank, California, United States • Valhalla, New York, United States • Cleveland, Ohio, United States +4 more locations

COMPLETEDPhase 238 miles

Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases

NCT00372775

This study will evaluate the safety, tolerability and efficacy of SU011248 in patients with non-small cell lung cancer with brain metastases.

Non-Small Cell Lung Cancer

Pfizer66 participantsStarted Mar 2007

Norwalk, Connecticut, United States • Cocoa Beach, Florida, United States • Merritt Island, Florida, United States +24 more locations

PreviousPage 63 of 65Next

A Phase 1-2, Multicenter, Open-Label Study of AEG35156 in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia and Indolent B-Cell Lymphomas

Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases

Leukemia Trials in Other Cities

Study to Assess the Efficacy and Safety of BDP HFA Nasal Aerosol in Patients 12 Years and Older With SAR

Repeat-Dose of Forodesine Hydrochloride (BCX-1777) Infusion in Patients With Advanced T-Cell Leukemia

A Pilot Study of OSI-461 in Patients With Chronic Lymphocytic Leukemia (CLL)

Trial of STAHIST in Seasonal Allergic Rhinitis

Evaluate the Effect of Omalizumab on Markers of Asthma Impairment in Patients With Persistent Allergic Asthma

Efficacy of 400 Mg Versus 800 Mg Imatinib in Chronic Myeloid Leukemia in Chronic Phase Patients - TOPS (Tyrosine Kinase Inhibitor Optimization and Selectivity)

Study of XL281 in Adults With Solid Tumors

A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC

Extension Study With Tosedostat in Relapsed/Refractory Acute Myeloid Leukemia

Forodesine Hydrochloride (BCX-1777) for B-Cell Acute Lymphoblastic Leukemia

Phase 1-2a Dose-Ranging Study of TLK286 in Combination With Docetaxel in Platinum-Resistant Non-Small Cell Lung Cancer

Phase 2 Study of TLK286 Administered Weekly in Advanced Non-Small Cell Lung Cancer

Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors

Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study

Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer

Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer

A Study of Nimotuzumab in Combination With External Radiotherapy in Non-Small Cell Lung Cancer

Safety/Efficacy Study of Immunoconjugate With Docetaxel in Non-small Cell Lung Carcinoma

Other Conditions in Texas